AU3745895A - Use of gaba antagonists in the treatment of emesis - Google Patents

Use of gaba antagonists in the treatment of emesis

Info

Publication number
AU3745895A
AU3745895A AU37458/95A AU3745895A AU3745895A AU 3745895 A AU3745895 A AU 3745895A AU 37458/95 A AU37458/95 A AU 37458/95A AU 3745895 A AU3745895 A AU 3745895A AU 3745895 A AU3745895 A AU 3745895A
Authority
AU
Australia
Prior art keywords
emesis
treatment
gaba antagonists
gaba
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37458/95A
Inventor
David Edmund Bays
Charanjit Bountra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU3745895A publication Critical patent/AU3745895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
AU37458/95A 1994-10-14 1995-10-12 Use of gaba antagonists in the treatment of emesis Abandoned AU3745895A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420784A GB9420784D0 (en) 1994-10-14 1994-10-14 Medicaments
PCT/EP1995/004025 WO1996011680A2 (en) 1994-10-14 1995-10-12 Use of gaba agonists in the treatment of emesis

Publications (1)

Publication Number Publication Date
AU3745895A true AU3745895A (en) 1996-05-06

Family

ID=10762886

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37458/95A Abandoned AU3745895A (en) 1994-10-14 1995-10-12 Use of gaba antagonists in the treatment of emesis

Country Status (3)

Country Link
AU (1) AU3745895A (en)
GB (1) GB9420784D0 (en)
WO (1) WO1996011680A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2255652C (en) 1996-07-24 2004-07-13 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
AU8668598A (en) 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
EP0974351A3 (en) * 1998-04-24 2000-12-13 Jouveinal Medicament for preventing and treating gastrointestinal damage
EP1077692B1 (en) * 1998-05-15 2004-07-28 Warner-Lambert Company LLC Amino acid stabilized gabapentin and pregabalin preparations and process for preparing the same
EP1031350A1 (en) * 1999-02-23 2000-08-30 Warner-Lambert Company Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
SE9904507D0 (en) 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904508D0 (en) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
AR033779A1 (en) 2001-06-08 2004-01-07 Astrazeneca Ab USEFUL COMPOUNDS IN REFLUX DISEASE
US20050090554A1 (en) * 2003-09-12 2005-04-28 John Devane Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists
EP3350187A1 (en) 2015-09-15 2018-07-25 AbbVie Inc. Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
WO2018048868A1 (en) * 2016-09-07 2018-03-15 The Children's Hospital Of Philadelphia Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder
CN111603560A (en) * 2020-06-22 2020-09-01 泉州台商投资区秋鑫茶业有限公司 Application of tea gamma-aminobutyric acid in tumor radiotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5015793B2 (en) * 1972-06-07 1975-06-07
DE3150486A1 (en) * 1981-12-19 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt IMIDAZO (4,5-C) PYRIDINE, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND METHOD FOR THE PRODUCTION THEREOF
FR2597100A1 (en) * 1986-01-21 1987-10-16 Nippon Shinyaku Co Ltd PYROGLUTAMIDE DERIVATIVES
US4952573A (en) * 1988-03-23 1990-08-28 Laboratoirs Alcon S.A. Compounds having GABA like activity, and use of same in tissue irrigating solutions
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5182290A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain oxazoloquinolinones; a new class of GABA brain receptor ligands
GB9125615D0 (en) * 1991-12-02 1992-01-29 Wyeth John & Brother Ltd Amines
US5266698A (en) * 1992-04-30 1993-11-30 Neurogen Corporation Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
GB9308430D0 (en) * 1993-04-23 1993-06-09 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
WO1996011680A3 (en) 1996-06-27
WO1996011680A2 (en) 1996-04-25
GB9420784D0 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
IL110434A0 (en) Method for making dental restoration and the dental restoration made thereby
AU3401895A (en) Spiro-azabicyclic compounds useful in therapy
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU3196295A (en) Dioxide-containing compositions for use in the eye
CA2195213A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
AU1542895A (en) Surface treatment
AU3745895A (en) Use of gaba antagonists in the treatment of emesis
ZA964762B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
ZA964761B (en) Peptidyl heterocycles useful in the treatment of thrombin related disorders.
AU2418499A (en) Org-5222 in the treatment of depression
AU9052991A (en) Use of angiotensin ii antagonist in the treatment of infarction
IL114305A0 (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters and their use
AU2554595A (en) Compositions and uses thereof in the diagnosis of psoriasis
AU1870292A (en) Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity
AU2801595A (en) Water treatment
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU2160697A (en) Nsaids in the treatment of pruritus
IL117191A0 (en) Process for the preparation of oxazolidinones and their use
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
AU3838695A (en) Use of the bio-spectrum in animal embryo-engineering
GB9726223D0 (en) The treatment of materials
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
CA2248753A1 (en) Use of olanzapine for treating excessive aggression
AU2708597A (en) An improvement in the treatment of wastes
AU1587295A (en) The treatment of gaseous substances